1-4 of 4
Zheng Huang
Close
Sort by
Journal Articles

FEIBA® and Novoseven® Neutralize the Anticoagulant Effects of a Novel Small Molecule FXIa Inhibitor BMS-986177/JNJ-70033093 in Human Plasma and Whole Blood in Vitro

Matthew W Bunce, PhD, Zheng Huang Devine, PhD, Madhu Chintala, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-136378
Published: 2020
Journal Articles

Measuring the Anticoagulation Effects of Exosite I Thrombin Inhibitors: Utility and Limitations of Clotting Assays, Thromboelastography, and Calibrated Automated Thrombography

Matthew Bunce, PhD, Zheng Huang Devine, PhD, Madhu Chintala, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1115.
https://doi.org/10.1182/blood.V130.Suppl_1.1115.1115
Published: 2017
Journal Articles

Preferential Inhibition of Fibrin Mediated Thrombosis in Rodent Models By JNJ-9375, a Novel exosite1 Thrombin Inhibitor

Madhu Chintala, PhD, Qiu Li, BS, Zheng Huang Devine, PhD, Matthew Bunce, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3712.
https://doi.org/10.1182/blood.V130.Suppl_1.3712.3712
Published: 2017
Journal Articles

MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4

Qiang Wang, Zheng Huang, Huiling Xue, Chengcheng Jin, Xiu-Li Ju, Jing-Dong J. Han, Ye-Guang Chen
Journal: Blood
Blood (2008) 111 (2): 588–595.
https://doi.org/10.1182/blood-2007-05-092718
Published: 2008